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Abstract
Background: Metabolic syndrome (MetS) is correlated with arterial stiffness and can be evaluated by brachial-
ankle pulse wave velocity (baPWV). We investigated potential associations between MetS and baPWV in a
Chinese community population.
Methods: The community-based Asymptomatic Polyvascular Abnormalities in Community study examined
asymptomatic polyvascular abnormalities in a Chinese population aged ≥40 years. The relationship between
MetS and its components and baPWV was analyzed by multivariate logistic and linear regression models.
Results: Out of 5181 study participants, 1271 subjects (24.53%) had MetS. Mean values of baPWV in subjects
with 0, 1, 2,3, 4, and 5 components of MetS were 1430, 1526, 1647, 1676,1740, and 1860 cm/s, respectively
(p < 0.001 for trend). After adjusting for confounding risk factors, MetS was significantly associated with baPWV
(odds ratio [OR]: 2.74; 95% CI: 2.28, 3.30). Among the five components of MetS, elevated blood pressure was
the most important factor for baPWV. All models of multivariate linear regression analysis showed a significant
positive correlation between the increasing numbers of MetS components and baPWV (p < 0.0001).
Conclusions: baPWV was associated with MetS and was greater with increasing numbers of MetS
components. Elevated blood pressure was the most important factor for baPWV.
Keywords: Brachial-ankle pulse wave velocity, Metabolic syndrome, Arterial stiffnes, Cardio-cerebrovascular
diseases
Background
Metabolic syndrome (MetS) is a pre-atherosclerotic state
which involves a cluster of factors, such as abdominal
obesity, arterial hypertension, dyslipidemia, and hypergly-
cemia, and is closely associated with a marked increase in
the risk of cardio-cerebrovascular diseases and type 2
diabetes mellitus [1–3]. Some studies have shown that
MetS is correlated with arterial stiffness. Nakanishi et al.
suggested that persistent MetS conditions can deteriorate
the severity of arterial stiffness [4, 5]. Furthermore,
Tomiyama et al. suggested that an improvement in MetS
status could delay the progression of atherosclerosis [6].
Pulse wave velocity is an objective valid index of arterial
stiffness and is widely used for non-invasive evaluation of
subclinical atherosclerotic changes [7]. Brachial-ankle
pulse wave velocity (baPWV), a type of pulse wave vel-
ocity, is a promising test method that can assess the stiff-
ness of both aortic and peripheral arteries [8, 9]. baPWV
not only reflects early atherosclerotic change [10–12], but
also serves as a valuable predictor of mortality due to
cardio-cerebrovascular events [13]. In the past decade,
studies have investigated the relationship between arterial
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stiffness measured by baPWV and the components of
MetS in different populations worldwide. However, the
association of baPWV with MetS is not understood well.
The correlation between baPWV and MetS and its com-
ponents may be different based on different populations,
regions and cultural diet.
The purpose of the present study was to evaluate the
relationship between baPWV and MetS and its individual
components in a large sample size of 5181 community-
based subjects in the northern region of China, and to




The Asymptomatic Polyvascular Abnormalities Community
(APAC) study is a community-based observational pro-
spective, long-term follow-up study to investigate the
epidemiology of asymptomatic polyvascular abnormalities
in Chinese adults [14]. The study cohort was a subgroup of
a previously described population of the Kailuan study [15].
Data about patient demographics , clinical characteristics
(physical examination, laboratory tests, carotid duplex
ultrasound and transcranial Doppler examinations),
and also finished structured interviews with a standard-
ized questionnaire performed by trained investigators.
Anthropometric indices included height and weight.
Body mass index (BMI) was calculated as body weight
(kg) divided by the square of body height (m2). Blood
pressure was measured twice with an appropriate cuff
size in relation to arm size, in the participants with the
supine position after 10 min resting. The average of the
two readings was used. However, if the difference be-
tween the two measurements exceeded 5 mmHg, a
third reading would be conducted, and the average of
three readings was recorded and analyzed. Smoking
was defined as at least one cigarette per day for more
than a year. Alcohol abuse was defined as alcohol in-
take of at least 90 and 45 g of liquor a day for men and
women, respectively, for more than 1 year. Smoking or
drinking cessation was considered only if it lasted for at
least 1 year. Details of the APAC study design and the
information on baseline characteristics have been pub-
lished previously. The community is part of a large coal
mining industry in Tangshan, Hebei Province [15, 16],
China. The study protocol was approved by the Ethics
Committees of the Kailuan General Hospital and the
Beijing Tiantan Hospital, and informed consent was
obtained from all participants.
Definition of MetS
MetS was defined using previously published criteria
from the International Diabetes Federation [11]. The
definition included the presence of central obesity (waist
circumference >90 cm for Chinese men and >80 cm for
Chinese women), plus any two of the following factors:
triglycerides >150 mg/dl (1.7 mmol/L) or obtaining ther-
apy for increased triglyceride (TG) concentrations; high-
density lipoprotein cholesterol (HDL-C), 40 mg/dl (1.03
mmol/L) in men and 50 mg/dl (1.29 mmol/L) in women,
or obtaining therapy for low HDL-C level; systolic blood
pressure (BP) >130 mmHg or diastolic BP >85 mmHg,
or treatment of previously diagnosed arterial hyperten-
sion; fasting plasma glucose >100 mg/dl (5.6 mmol/L) or
previously diagnosed type 2 diabetes mellitus.
Measurement of baPWV
Bilateral baPWV was evaluated by utilizing aBP-203RPE
III device ( Omron Healthcare, Kyoto, Japan). Details
about this instrument and its use have been described,
and clinical validation and good reproducibility have
been confirmed [8]. All examinations were carried out
by specially trained physicians and nurses. All subjects
were light clothing and underwent examination under
resting-state by placement of the subject in a supine
position without a pillow. Electrodes of the electrocar-
diograph were located in both wrists, a stethoscope was
located in the left border of the sternum for acquiring
heart sounds, and cuffs were wrapped with certain strain
on both the upper arms and ankles. The lower border of
the brachial cuff was located 2–3 cm above the chelidon,
and the lower border of ankle cuff was located 1–2 cm
above the medial malleolus. Two measured values were
recorded from both sides of the body, while the second
value of baPWV was utilized. Then we used the higher
of the left and right baPWV values for analyses [17].
Arterial stiffness was considered as baPWV ≥1400 cm/s,
since this is what has been identified as an independent
risk factor in the Framingham score and can distinguish
patients with atherosclerotic cardiovascular disease. Dia-
betes was considered as fasting plasma glucose concentra-
tion of ≥7.0 mmol/L or treatment for diabetes with drug
or insulin. Hypertension was defined as systolic BP >130
mmHg or diastolic BP >85 mmHg or on drug treatment
for hypertension.
Statistical analysis
The continuous variables and categorical data are expressed
as the mean ± standard deviation (SD) and percentage,
respectively. The Student’s t-test or ANOVA test was used
to address non-paired samples for the comparison of
normally distributed parameters, and the Wilcoxon or
Kruskal-Wallis test for the comparison of non-parametric
variables. The qualitative variables were compared by using
chi-squared test. Four multivariate logistic regression ana-
lyses were performed to calculate odds ratio (OR) and 95%
confidence interval (CI) for the associations of MetS or the
number of MetS components (the 0 MetS component
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group was used as the reference category). Arterial stiffness
was defined as baPWV ≥1400 cm/s. Model 1 was the crude
model; Model 2 adjusted for age and gender; Model 3
adjusted for age, gender, level of education, income, smok-
ing, alcohol abuse, and physical activity; and Model 4
adjusted for age, gender, level of education, income, smok-
ing, alcohol abuse, amount of physical activity, BMI, and
serum concentrations of low-density lipoprotein cholesterol
(LDL-C) and high-sensitivity C-reactive protein. Finally, for
each model, a trend test was performed after the number of
MetS components as a continuous variable entering into
the model. Furthermore, a multivariate linear regression
was applied to analyze the independent associations
between baPWV and MetS. Differences were considered
statistically significant only when p-value was <0.05. All
data were analyzed with a commercially available software
Table 1 Clinical and biochemical characteristics of subjects with and without metabolic syndrome
Variables Total (n = 5181) MetS group (n = 1271) Non-MetS group (n = 3910) P value
Age (year) 55.16 ± 11.80 56.29 ± 10.47 54.79 ± 12.18 <0.0001
Male, n (%) 3108 (59.99) 701 (55.15) 2407 (61.56) <0.0001
Education, n (%)
Illiteracy/Primary School 638 (12.31) 188 (14.79) 450 (11.51) 0.0004
Middle School 2295 (44.30) 583 (45.87) 1712 (43.79)
High School or Higher 2248 (43.39) 500 (39.34) 1748 (44.71)
Income, n (%)
< ¥1000 1239 (23.91) 264 (20.77) 975 (24.94) 0.0001
¥1000–3000 3431 (66.22) 903 (71.05) 2528 (64.65)
> ¥3000 511 (9.86) 104 (8.18) 407 (10.41)
Body Mass Index (kg/m2) 24.94 ± 3.25 27.38 ± 3.00 24.15 ± 2.92 <0.0001
Waist circumference (cm) 86.12 ± 9.66 93.90 ± 7.26 83.59 ± 8.96 <0.0001
Waist-to hip ratio 0.88 ± 0.06 0.91 ± 0.06 0.87 ± 0.06 <0.0001
Systolic Blood Pressure (mmHg) 131.33 ± 20.04 141.18 ± 18.36 128.12 ± 19.51 <0.0001
Diastolic Blood Pressure (mmHg) 82.86 ± 11.06 88.10 ± 10.79 81.16 ± 10.60 <0.0001
Fasting Plasma Glucose (mmol/L) 5.59 ± 1.51 6.37 ± 2.01 5.33 ± 1.20 <0.0001
Total cholesterol (mmol/L) 1.53 ± 0.70 1.69 ± 0.74 1.48 ± 0.68 <0.0001
Triglycerides (mmol/L) 1.68 ± 1.42 2.60 ± 2.01 0.38 ± 1.00 <0.0001
High-Density Lipoprotein-Cholesterol ( mmol/L) 1.63 ± 0.46 1.45 ± 0.41 1.68 ± 0.46 <0.0001
Low-Density Lipoprotein-Cholesterol (mmol/L) 2.63 ± 0.74 2.76 ± 0.87 2.58 ± 0.69 <0.0001
High-Sensitivity C-Reactive Protein 2.13 ± 4.18 2.77 ± 4.25 1.92 ± 4.14 <0.0001
bapwv (cm/s) 1588.40 ± 401.62 1703.30 ± 371.57 1551.06 ± 403.98 <0.0001
Hypertension, n (%) 2500 (48.25) 980 (77.10) 1520 (38.87) <0.0001
Diabetes mellitus, n (%) 629 (12.14) 348 (27.38) 281 (7.19) <0.0001
Smoking, n (%)
Never 3233 (62.40) 812 (63.89) 2421 (61.92) 0.3655
Former 291 (5.62) 73 (5.74) 218 (5.58)
Current 1657 (31.98) 386 (30.37) 1271 (32.51)
Alcohol abuse, n (%)
Never 3391 (65.51) 833 (65.54) 2561 (65.50) 0.7074
Former 81 (1.56) 23 (1.81) 58 (1.48)
Current 1706 (32.93) 415 (32.65) 1291 (33.02)
Physical Activity, n (%)
Inactive 2087 (40.28) 506 (39.81) 1581 (40.43) 0.6289
Moderately Active 1312 (25.32) 314 (24.70) 998 (25.52)
Very Active 1782 (34.39) 451 (35.48) 1331 (34.04)
MetS metabolic syndrome, baPWV brachial-ankle pulse wave velocity
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program (SAS software version 9.3; SAS Institute Inc., Cary,
NC, USA).
Results
Of the 5440 subjects who were originally included
into the APAC study, we excluded 218 participants
without measurement of baPWV and 41 individuals
without MetS. Eventually, 5181 participants (3108
men, 2073 women) with a mean age of 55.16 ± 11.80
years (range: 40–94 years) were included in the
present investigation. The distribution of demograph-
ics, anthropometric measurement, baPWV, vascular
risk factors and living habits according to presence of
metabolic syndrome are summarized in Table 1. At
baseline, 1271 out of 5181 subjects (24.53%) had
MetS. Compared with those with no MetS, the inci-
dence of MetS was found significantly in older sub-
jects, in higher proportion of men, in subjects with
lower level of education, subjects at the middle-
income level (p < 0.001 for all). There were no statisti-
cally significant differences for smoking (p = 0.3655),
drinking (p = 0.7074) and physical activity (p = 0.6289)
between the MetS group and the group without
MetS. The baPWV values were significantly and posi-
tively correlated with the values of the components of
MetS (p < 0.0001).
Mean values of baPWV in subjects with 0, 1, 2,3, 4,
and 5 features of MetS were 1430, 1526, 1647,
1676,1740, and 1860 cm/s, respectively (p < 0.001 for
trend) (Fig. 1).
The characteristics of the participants in relation to
baPWV are shown in Table 2. There were significant dif-
ferences between the two groups in mean age and sex
(p < 0.0001 for both). The percentage of MetS and its
components was higher in the arterial stiffness group
(baPWV ≥1400 cm/s) than the non-arterial stiffness
group (baPWV <1400 cm/s), and a higher proportion of
subjects in the arterial stiffness group than those in the
non-arterial stiffness group had exceeded thresholds for
BMI, waist circumference, waist-to-hip ratio, systolic BP,
diastolic BP, fasting plasma glucose, total cholesterol,
triglycerides, HDL-C, LDL-C, and high-sensitivity C-
reactive protein (p < 0.0001 for all). There was a trend
toward higher age, education, hypertension, diabetes
mellitus, smoking, alcohol abuse, and less or no physical
activity in the arterial stiffness group than in the non-
arterial stiffness group (p < 0.0001 for all). The severity
of central obesity, elevated arterial BP, raised fasting
plasma glucose and TG, and reduced HDL-C concentra-
tion and the degree of MetS were significantly higher in
the arterial stiffness group than in the group without
arterial stiffness.
In all four models of the multivariable logistic regres-
sion analysis, the risk of arterial stiffness increased
significantly (p < 0.0001) with increasing number of
MetS components (Table 3). After adjustment for age,
gender, level of education, income, smoking, alcohol
abuse, amount of physical activity, BMI, and serum con-
centrations of LDL-C, high-sensitivity C-reactive protein
(Model 4), MetS remained significantly associated with
Fig. 1 Mean baPWV according to the number (0, 1, 2, 3, 4, 5) of components of metabolic syndrome. MetS: metabolic syndrome; baPWV: brachial
ankle pulse wave velocity
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Table 2 Clinical and biochemical characteristics of baPWV
Variables baPWV < 1400cm/s (n = 1965) baPWV≥ 1400cm/s (n = 3216) P value
Age (year) 48.14 ± 6.39 59.45 ± 12.28 <0.0001
Male, n 944 (48.04) 2164 (67.29) <0.0001
Education, n (%)
Illiteracy/Primary School 97 (4.94) 541 (16.82) <0.0001
Middle School 856 (43.56) 1439 (44.75)
High School or Higher 1012 (51.50) 1236 (38.43)
Income, n (%)
< ¥1000 530 (26.97) 709 (22.05) <0.0001
¥1000–3000 1278 (65.04) 2153 (66.95)
> ¥3000 157 (7.99) 354 (11.01)
Body Mass Index (kg/m2) 24.05 ± 3.09 25.12 ± 3.34 <0.0001
Waist circumference (cm) 83.36 ± 9.55 87.80 ± 9.33 <0.0001
Waist-to hip ratio 0.86 ± 0.06 0.89 ± 0.06 <0.0001
Systolic Blood Pressure (mmHg) 118.78 ± 14.16 138.99 ± 19.22 <0.0001
Diastolic Blood Pressure (mmHg) 79.11 ± 9.62 85.15 ± 11.25 <0.0001
Fasting Plasma Glucose (mmol/L) 5.24 ± 0.96 5.80 ± 1.73 <0.0001
Total cholesterol (mmol/L) 1.42 ± 0.64 1.60 ± 0.73 <0.0001
Triglycerides (mmol/L) 1.50 ± 1.25 1.78 ± 1.50 <0.0001
High-Density Lipoprotein-Cholesterol (mmol/L) 1.67 ± 0.47 1.60 ± 0.44 <0.0001
Low-Density Lipoprotein-Cholesterol (mmol/L) 2.54 ± 0.66 2.68 ± 0.78 <0.0001
High-Sensitivity C-Reactive Protein 1.51 ± 2.83 2.51 ± 4.79 <0.0001
Hypertension, n (%) 427 (21.73) 2073 (64.46) <0.0001
Diabetes mellitus, n (%) 94 (4.78) 535 (16.64) <0.0001
Smoking, n (%)
Never 1334 (67.89) 1899 (59.05) <0.0001
Former 59 (3.00) 232 (7.21)
Current 572 (29.11) 1085 (33.74)
Alcohol abuse, n (%)
Never 1401 (71.30) 1993 (61.97) <0.0001
Former 18 (0.92) 63 (1.96)
Current 546 (27.79) 1160 (36.07)
Physical Activity, n (%)
Inactive 877 (44.63) 1210 (37.62) <0.0001
Moderately Active 561 (28.55) 751 (23.35)
Very Active 527 (26.82) 1255 (39.02)
Metabolic Syndrome, n (%) 261 (13.28) 1010 (31.41) <0.0001
Metabolic Syndrome Components
Central Obesity, n (%) 907 (46.16) 1838 (57.15) <0.0001
Raised Triglycerides, n (%) 523 (26.62) 1152 (35.82) <0.0001
Reduced High-Density Lipoprotein-Cholesterol, n (%) 169 (8.60) 419 (13.03) <0.0001
Raised Blood Pressure, n (%) 378 (19.24) 1820 (56.59) <0.0001
Raised Fasting Plasma Glucose, n (%) 455 (23.16) 1267 (39.40) <0.0001
Metabolic Syndrome (No. of Components)
0, n (%) 608 (30.94) 394 (12.25) <0.0001
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baPWV (OR: 2.74; 95% CI: 2.28–3.30). Among the five
components of MetS, raised BP was the most important
factor for baPWV.
The OR values were 4.60 for raised BP, 1.50 for raised
fasting plasma glucose, 1.48 for reduced HDL-C, 1.38
for raised triglycerides, and 1.18 for central obesity.
Using the subgroup with no component of MetS as
baseline, the ORs for the associations between the sub-
groups with 1, 2, 3, 4 and 5 MetS components and
baPWV were 1.97 (95% CI: 1.60, 2.43), 3.80 (95% CI:
3.04, 4.75), 5.70 (95% CI: 4.38, 7.42), 11.66 (95% CI: 8.16,
16.67), and 20.88 (95% CI: 8.37, 52.04), respectively. In
this multivariate model, the baPWV increased signifi-
cantly (p < 0.0001 for trend) with the number of MetS
components. The same held true for the three other
models of the multivariate analysis (Table 3).
Figure 2 shows the results of multiple logistic regression
analysis of the association between MetS components and
baPWV in males and females (Model 4). In this model,
metabolic syndrome and its components were associated
with increased baPWV in both males and females. Among
the five components of MetS, raised BP was still the most
important factor for baPWV. Furthermore, regardless of
gender, all models of the multivariate linear regression
analysis in Table 4 showed a significant positive correl-
ation between baPWV and MetS (p < 0.0001).
Discussion
In our investigation based on a community population
in northern China, baPWV was significantly associated
with MetS and baPWV, and there was greater statistical
significance with increasing numbers of MetS compo-
nents. Among the conditions of central obesity, raised
triglycerides, reduced HDL-C, raised BP, and raised
fasting plasma glucose; raised BP was the strongest de-
terminant for baPWV. Furthermore, the mean velocity
of baPWV in subjects with five components of MetS
had a 1.3 times faster than individuals with no MetS.
Table 2 Clinical and biochemical characteristics of baPWV (Continued)
1, n (%) 644 (32.77) 751 (23.35)
2, n (%) 427 (21.73) 959 (29.82)
3, n (%) 216 (10.99) 681 (21.18)
4, n (%) 64 (3.26) 371 (11.54)
5, n (%) 6 (0.31) 60 (1.87)
baPWV brachial ankle pulse wave velocity
Table 3 Odds ratio and 95% CI of baPWV for MetS/components in multiple logistic regression analysis
Variables Model 1 Model 2 Model 3 Model 4
Metabolic Syndrome 2.99 (2.57–3.47) 2.99 (2.54–3.53) 2.93 (2.48–3.46) 2.74 (2.28–3.30)
Central Obesity 1.10 (0.97–1.25) 1.11 (0.96–1.29) 1.08 (0.93–1.26) 1.18 (0.98–1.42)
Raised Triglycerides 1.12 (0.98–1.29) 1.36 (1.16–1.59) 1.36 (1.17–1.60) 1.38 (1.17–1.62)
Reduced High-Density Lipoprotein Cholesterol 1.46 (1.19–1.79) 1.39 (1.10–1.76) 1.40 (1.10–1.78) 1.48 (1.17–1.89)
Raised Blood Pressure 4.99 (4.36–5.71) 4.51 (3.88–5.25) 4.44 (3.82–5.18) 4.60 (3.93–5.39)
Raised Fasting Plasma Glucose 1.76 (1.54–2.01) 1.60 (1.38–1.14) 1.58 (1.35–1.84) 1.50 (1.28–1.76)
No. of Components
0 Reference Reference Reference Reference
1 1.80 (1.53–2.12) 1.89 (1.55–2.31) 1.87 (1.53–2.29) 1.97 (1.60–2.43)
2 3.47 (2.92–4.11) 3.51 (2.86–4.30) 3.38 (2.76–4.15) 3.80 (3.04–4.75)
3 4.86 (3.99–5.94) 4.98 (3.96–6.27) 4.80 (3.81–6.05) 5.70 (4.38–7.42)
4 8.94 (6.67–12.00) 9.82 (7.11–13.56) 9.39 (6.79–12.98) 11.66 (8.16–16.67)
5 15.43 (6.60–36.06) 15.80 (6.51–38.32) 15.35 (6.30–37.38) 20.88 (8.37–52.04)
P for trend <0.0001 <0.0001 <0.0001 <0.0001
MetS metabolic syndrome, baPWV brachial ankle pulse wave velocity
Model 1: unadjusted
Model 2: adjusted for age and gender
Model 3: adjusted for age, gender, level of education, income, smoking, alcohol abuse, and amount of physical activity
Model 4: adjusted for age, gender, level of education, income, smoking, alcohol abuse, amount of physical activity, body mass index, and serum concentrations of
low-density lipoprotein cholesterol, high-sensitivity C-reactive protein
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Fig. 2 Odds ratio and 95% CI of baPWV for MetS/its Components in Multiple Logistic Regression Analysis in different gradation of gender after
adjusted. MetS: metabolic syndrome; baPWV: brachial ankle pulse wave velocity; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; BP:
blood pressure; FPG: fasting plasma glucose
Table 4 Multivariate linear regression analysis models of associations between number of MetS components and the level of baPWV
Variables MetS Increasing 1 component of MetS
B (95%CI) P Value B (95%CI) P Value
Model 1 152.24 (127.16–177.32) <0.0001 81.21 (72.82–89.60) <0.0001
Model 2 125.39 (106.03–144.75) <0.0001 64.40 (57.92–70.88) <0.0001
Model 3 122.17 (102.80–141.53) <0.0001 63.07 (56.57–69.58) <0.0001
Model 4 132.74 (111.13–154.35) <0.0001 77.71 (70.12–85.31) <0.0001
Female
Model 1 267.94 (235.39–300.50) <0.0001 118.25 (107.83–128.66) <0.0001
Model 2 129.63 (104.40–154.86) <0.0001 59.27 (50.69–67.85) <0.0001
Model 3 125.63 (100.30–150.95) <0.0001 58.03 (49.38–66.68) <0.0001
Model 4 127.85 (100.20–155.50) <0.0001 66.78 (56.80–76.76) <0.0001
Male
Model 1 82.90 (47.96–117.83) <0.0001 52.95 (41.01–64.89) <0.0001
Model 2 107.28 (79.16–135.40) <0.0001 63.80 (54.27–73.32) <0.0001
Model 3 105.18 (77.09–133.26) <0.0001 62.51 (52.97–72.05) <0.0001
Model 4 126.18 (94.48–157.89) <0.0001 81.93 (70.80–93.06) <0.0001
MetS metabolic syndrome, baPWV brachial ankle pulse wave velocity
Model 1: unadjusted
Model 2: adjusted for age and gender
Model 3: adjusted for age, gender, level of education, income, smoking, alcohol abuse, and amount of physical activity
Model 4: adjusted for age, gender, level of education, income, smoking, alcohol abuse, amount of physical activity, body mass index, and serum concentrations of
low-density lipoprotein cholesterol, high-sensitivity C-reactive protein
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Our findings demonstrate that components of MetS
for the influence of vasculature appear to be additive.
This result was consistent with those of other studies
[5, 10, 18]. The individuals with more risk factors
have substantially greater baPWV values than those
with fewer risk factors, which can be explained by
baPWV being closely associated with severity of arter-
ial stiffness.
In a Japanese population study, Nakanishi et al. [5]
showed that age-adjusted mean values of baPWV were
increased with clustered features of MetS in both sexes.
In addition, insulin resistance was closely associated with
the risk for increased baPWV or increased arterial stiff-
ness. However, in our study, raised BP was the strongest
determinant for risk of increased baPWV. However, the
mechanism by which MetS might increase baPWV
remains unclear. One probable explanation for our find-
ings is that elevated BP can increase baPWV by directly
acting on the arterial wall.
Angelo Scuteri et al. [11] conducted a study involving
nine cohorts representing eight different European
countries and the United States and suggested that the
“risky” cluster of raised triglycerides, raised BP, central
obesity, raised fasting plasma glucose, and central obesity
was significantly associated with extremely stiff arteries.
They also showed the highest prevalence in Sardinian,
Italian, British, and Belgian cohorts, and the lowest in co-
horts from Sweden and the United States. However,
Young-Kwon Kim [18] found that the other individual
MetS components, except for a raised BP, do not affect
arterial stiffness independently.
Another study [19] including 8599 subjects in south
China suggested that baPWV was significantly higher in
subjects with MetS than in those without MetS (p < 0.001
for both sexes). All the metabolic components were corre-
lated to baPWV in the male and female subjects except
low HDL-C and high urine acid in the male group. BP
and fasting plasma glucose had the strongest correlation
factors. The baPWV values were positively correlated with
advanced age (p < 0.001) and the values of the MetS com-
ponents, and this correlation was stronger in females than
in males (p < 0.001), which is different from the results
summarized by Wang et al. [20].
Although the current study focused on the feasibility
of a non-invasive baPWV examination as an effective
tool to screen community populations at high risk of
MetS, appropriate cut-off points or valid intervals of
baPWV were not achieved [20–23]. With the marked
growth of living standards in China, prevalence of MetS
has increased and has resulted in serious social burden
[24, 25]. Arterial stiffness is an indicator of arterial damage
and its increase with age has been demonstrated to be as-
sociated with an increased risk of cardio-cerebrovascular
diseases [26–29]. The clinical implication of our study is
that community populations with baPWV >1400 cm/
s, advanced age, and MetS with reduced HDL-C,
raised BP and raised fasting plasma glucose, might
benefit from immediate intervention strategies which
reduce the risk of further cardiovascular disease mor-
bidity and mortality [30].
There are some potential limitations in our study.
First, our community-based investigation, which is a
cross-sectional investigation, cannot prove a causal rela-
tionship, since this has to be demonstrated in a longitu-
dinal study. The data from this study only allows us to
summarize the relationships between baPWV and MetS
components, while the influence of MetS as a risk factor
for cardio-cerebrovascular diseases may be shown in
follow-up studies. Second, this study was based on the
participants of the large Kailuan Study which included
employees, retirees and their families of the Kailuan
Company. Although we used a rigid random sampling
method to reduce selection bias, the population of the
Kailuan Company does not necessarily represent the
populations of Hebei province. Finally, a crucial topic is
the alteration of the results of the baPWV measure-
ments by BP levels themselves.
Conclusions
In conclusion, our study is based on more than 5000
subjects, showing that increasing the number of MetS
components is significantly correlated with a risk for
increased baPWV in a northern China community-
based population. A decrease in arterial compliance or
an increase in arterial stiffness was shown to be related
to a risk for cardiovascular mortality, for this reason, indi-
viduals with clustered components of MetS might benefit
from immediate interventions, including frequent exer-
cise, reasonable diet regulation, and medical therapy for
MetS. Furthermore, baPWV may be taken into consider-
ation as a screening index in community-based healthcare
plans and as a tool for evaluating the risk of cardio-
cerebrovascular diseases in clinical practice.
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